+1 (646) 663-5829 | +91 702 496 8807

  sales@regionalresearchreports.com

Non Small Cell Lung Cancer Drugs Market Size, Share, and COVID-19 Impact Analysis by Segmentation, Regions, Company Market Share, and Regional Forecast, 2022-2030

Publish Date: Mar 2024
Report ID:HC-1100
Base Year:2023
Report Format:PDF, Excel
Report Pages:199
Region:Global

Table of Content

  1. Global Non Small Cell Lung Cancer Drugs Market Introduction and Market Overview
    1. Objective of the Study
    2. Global Non Small Cell Lung Cancer Drugs Market Scope and Market Estimation
      1. Global Non Small Cell Lung Cancer Drugs Overall Market Size (US$ Mn), Market CAGR (%), Market Forecast (2022-2030)
      2. Global Non Small Cell Lung Cancer Drugs Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2022-2030
    3. Market Segmentation
      1. Type of Global Non Small Cell Lung Cancer Drugs Market
      2. Application of Global Non Small Cell Lung Cancer Drugs Market
      3. Region of Global Non Small Cell Lung Cancer Drugs Market
  2. Global Non Small Cell Lung Cancer Drugs Market - Executive Summary
    1. Key Findings
      1. Top Impacting Factors
      2. Top Investment Pockets
      3. Market Attractiveness Analysis
    2. Key Companies Introduction
  3. Market Factor Analysis
    1. Global Non Small Cell Lung Cancer Drugs Market Industry Development Trends under COVID-19 Outbreak
      1. Global COVID-19 Status Overview
      2. Influence of COVID-19 Outbreak on Global Non Small Cell Lung Cancer Drugs Market Industry Development
    2. Market Dynamics (Growth Influencers)
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Impact Analysis of Drivers and Restraints
    3. Ecosystem/ Value Chain Analysis
    4. Porter’s Five Forces Analysis
    5. SWOT Analysis
    6. PEST Analysis
    7. Market Opportunity Assessment – by Region (North America/ Europe/ Asia Pacific/ Middle East and Africa/ South America)
      1. By Type
      2. By Application
  4. Global Non Small Cell Lung Cancer Drugs Market: Estimates & Historic Trend Analysis (2017-2020)
  5. Global Non Small Cell Lung Cancer Drugs Market Estimates & Forecast Trend Analysis, by Type
    1. Non Small Cell Lung Cancer Drugs Market Share (%) Estimates and Forecasts, by Type, 2022 & 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Non Small Cell Lung Cancer Drugs Market Revenue (US$ Mn) Estimates and Forecasts, by Type, 2017 to 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    3. Biologics
    4. Small Molecule Targeted Therapy
    5. Chemotherapy
    6. Other
  6. Global Non Small Cell Lung Cancer Drugs Market Estimates & Forecast Trend Analysis, by Application
    1. Non Small Cell Lung Cancer Drugs Market Share (%) Estimates and Forecasts, by Application, 2022 & 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Non Small Cell Lung Cancer Drugs Market Revenue (US$ Mn) Estimates and Forecasts, by Application, 2017 to 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    3. Lung Adenocarcinoma
    4. Squamous Cell Lung Carcinoma
    5. Large-cell Lung Carcinoma
  7. Global Non Small Cell Lung Cancer Drugs Market Analysis and Forecast, by Region
    1. Non Small Cell Lung Cancer Drugs Market Share (%) Estimates and Forecasts, by Region, 2022 & 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Non Small Cell Lung Cancer Drugs Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2017 to 2030
      1. Key Market Trends, Growth Factors, and Opportunities
      2. North America
      3. Europe
      4. Asia Pacific
      5. Middle East and Africa
      6. South America
  8. North America Non Small Cell Lung Cancer Drugs Market: Estimates & Forecast Trend Analysis
    1. North America Market Assessments & Key Findings
    2. North America Non Small Cell Lung Cancer Drugs Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. North America Non Small Cell Lung Cancer Drugs Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Type
      2. By Application
      3. By Country
        1. U.S.
        2. Canada
        3. Mexico
  9. Europe Non Small Cell Lung Cancer Drugs Market: Estimates & Forecast Trend Analysis
    1. Europe Market Assessments & Key Findings
    2. Europe Non Small Cell Lung Cancer Drugs Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. Europe Non Small Cell Lung Cancer Drugs Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Type
      2. By Application
      3. By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Russia
        7. Rest of Europe
  10. Asia Pacific Non Small Cell Lung Cancer Drugs Market: Estimates & Forecast Trend Analysis
    1. Asia Pacific Market Assessments & Key Findings
    2. Asia Pacific Non Small Cell Lung Cancer Drugs Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. Asia Pacific Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Type
      2. By Application
      3. By Country
        1. China
        2. Japan
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia Pacific
  11. Middle East & Africa Non Small Cell Lung Cancer Drugs Market: Estimates & Forecast Trend Analysis
    1. Middle East & Africa Market Assessments & Key Findings
    2. Middle East & Africa Non Small Cell Lung Cancer Drugs Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. Middle East & Africa Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Type
      2. By Application
      3. By Country
        1. U.A.E.
        2. Saudi Arabia
        3. Egypt
        4. South Africa
        5. Rest of Middle East & Africa
  12. South America Non Small Cell Lung Cancer Drugs Market: Estimates & Forecast Trend Analysis
    1. South America Market Assessments & Key Findings
    2. South America Non Small Cell Lung Cancer Drugs Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. South America Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Type
      2. By Application
      3. By Country
        1. Brazil
        2. Argentina
        3. Colombia
        4. Rest of South America
  13. Manufacturing Cost Structure Analysis
    1. Raw Material and Suppliers
    2. Manufacturing Cost Structure Analysis of Non Small Cell Lung Cancer Drugs
    3. Manufacturing Process Analysis of Non Small Cell Lung Cancer Drugs
    4. Industry Chain Structure of Non Small Cell Lung Cancer Drugs
  14. Marketing, Distributors and Customer
    1. Sales Channel
      1. Direct Channels
      2. Indirect Channels
    2. Non Small Cell Lung Cancer Drugs Distributors
    3. Non Small Cell Lung Cancer Drugs Customer
  15. Competition Landscape
    1. Key Manufacturers Non Small Cell Lung Cancer Drugs Producing Area Distribution, Sales Area, Type
    2. Key Manufacturers Non Small Cell Lung Cancer Drugs Product Location Distribution
    3. Market Competition Matrix, by Leading Players
      1. Competition Landscape Analysis
      2. Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    4. List of Emerging, Prominent and Leading Players
    5. Major Mergers & Acquisitions, Partnership, Joint Venture, Expansions, Deals, Etc.
  16. Company Profiles
    1. AstraZeneca
      1. Company Information
      2. Non Small Cell Lung Cancer Drugs Product Offered
      3. Non Small Cell Lung Cancer Drugs Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    2. Bristol-Myers Squibb Company
      1. Company Information
      2. Non Small Cell Lung Cancer Drugs Product Offered
      3. Non Small Cell Lung Cancer Drugs Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    3. Eli Lilly and Company
      1. Company Information
      2. Non Small Cell Lung Cancer Drugs Product Offered
      3. Non Small Cell Lung Cancer Drugs Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    4. F. Hoffmann-La Roche Ltd
      1. Company Information
      2. Non Small Cell Lung Cancer Drugs Product Offered
      3. Non Small Cell Lung Cancer Drugs Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    5. Merck and Co., Inc.
      1. Company Information
      2. Non Small Cell Lung Cancer Drugs Product Offered
      3. Non Small Cell Lung Cancer Drugs Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    6. GlaxoSmithKline plc.
      1. Company Information
      2. Non Small Cell Lung Cancer Drugs Product Offered
      3. Non Small Cell Lung Cancer Drugs Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    7. F. Hoffmann-La Roche Ltd, Novartis AG
      1. Company Information
      2. Non Small Cell Lung Cancer Drugs Product Offered
      3. Non Small Cell Lung Cancer Drugs Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    8. Pfizer Inc.
      1. Company Information
      2. Non Small Cell Lung Cancer Drugs Product Offered
      3. Non Small Cell Lung Cancer Drugs Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    9. Takeda Pharmaceutical Company Limited.
      1. Company Information
      2. Non Small Cell Lung Cancer Drugs Product Offered
      3. Non Small Cell Lung Cancer Drugs Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    10. Ono Pharmaceutical Co., Ltd.
      1. Company Information
      2. Non Small Cell Lung Cancer Drugs Product Offered
      3. Non Small Cell Lung Cancer Drugs Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    11. Boehringer Ingelheim International Gmbh
      1. Company Information
      2. Non Small Cell Lung Cancer Drugs Product Offered
      3. Non Small Cell Lung Cancer Drugs Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    12. Merck & Co., Inc.
      1. Company Information
      2. Non Small Cell Lung Cancer Drugs Product Offered
      3. Non Small Cell Lung Cancer Drugs Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    13. Celgene Corporation
      1. Company Information
      2. Non Small Cell Lung Cancer Drugs Product Offered
      3. Non Small Cell Lung Cancer Drugs Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
  17. Assumptions and Research Methodology
  18. Conclusions and Recommendations
    1. Analysis and Suggestions on New Project Investment
    2. Research Findings and Conclusion

List of Tables

  1. Global Non Small Cell Lung Cancer Drugs Market Historic Analysis (US$ Mn), 2017-2021
  2. Global Non Small Cell Lung Cancer Drugs Market Forecast Opportunity Analysis (US$ Mn), 2022-2030
  3. Global Non Small Cell Lung Cancer Drugs Market Absolute $ Opportunity
  4. Global Non Small Cell Lung Cancer Drugs Market Analysis by Type, 2017-2030
  5. Global Non Small Cell Lung Cancer Drugs Market Analysis by Application, 2017-2030
  6. Global Non Small Cell Lung Cancer Drugs Market Analysis by Region, 2017-2030
  7. North America Non Small Cell Lung Cancer Drugs Market Absolute $ Opportunity
  8. North America Non Small Cell Lung Cancer Drugs Market Analysis by Type, 2017-2030
  9. North America Non Small Cell Lung Cancer Drugs Market Analysis by Application, 2017-2030
  10. North America Non Small Cell Lung Cancer Drugs Market Analysis by Country, 2017-2030
  11. South America Non Small Cell Lung Cancer Drugs Market Absolute $ Opportunity
  12. South America Non Small Cell Lung Cancer Drugs Market Analysis by Type, 2017-2030
  13. South America Non Small Cell Lung Cancer Drugs Market Analysis by Application, 2017-2030
  14. South America Non Small Cell Lung Cancer Drugs Market Analysis by Country, 2017-2030
  15. Europe Non Small Cell Lung Cancer Drugs Market Absolute $ Opportunity
  16. Europe Non Small Cell Lung Cancer Drugs Market Analysis by Type, 2017-2030
  17. Europe Non Small Cell Lung Cancer Drugs Market Analysis by Application, 2017-2030
  18. Europe Non Small Cell Lung Cancer Drugs Market Analysis by Country, 2017-2030
  19. Asia Pacific Non Small Cell Lung Cancer Drugs Market Absolute $ Opportunity
  20. Asia Pacific Non Small Cell Lung Cancer Drugs Market Analysis by Type, 2017-2030
  21. Asia Pacific Non Small Cell Lung Cancer Drugs Market Analysis by Application, 2017-2030
  22. Asia Pacific Non Small Cell Lung Cancer Drugs Market Analysis by Country, 2017-2030
  23. MEA Non Small Cell Lung Cancer Drugs Market Absolute $ Opportunity
  24. MEA Non Small Cell Lung Cancer Drugs Market Analysis by Type, 2017-2030
  25. MEA Non Small Cell Lung Cancer Drugs Market Analysis by Application, 2017-2030
  26. MEA Non Small Cell Lung Cancer Drugs Market Analysis by Country, 2017-2030

List of Figures

  1. Global Non Small Cell Lung Cancer Drugs Market Historic Y-o-Y Analysis (%), 2017-2021
  2. Global Non Small Cell Lung Cancer Drugs Market Forecast Y-o-Y Analysis (%), 2022-2030
  3. Global Non Small Cell Lung Cancer Drugs Market Share Analysis by Type, 2021 and 2030
  4. Global Non Small Cell Lung Cancer Drugs Market Share Analysis by Application, 2021 and 2030
  5. Global Non Small Cell Lung Cancer Drugs Market Share Analysis by Region, 2021 and 2030
  6. North America Non Small Cell Lung Cancer Drugs Market Share Analysis by Type, 2021 and 2030
  7. North America Non Small Cell Lung Cancer Drugs Market Share Analysis by Application, 2021 and 2030
  8. North America Non Small Cell Lung Cancer Drugs Market Share Analysis by Country, 2021 and 2030
  9. South America Non Small Cell Lung Cancer Drugs Market Share Analysis by Type, 2021 and 2030
  10. South America Non Small Cell Lung Cancer Drugs Market Share Analysis by Application, 2021 and 2030
  11. South America Non Small Cell Lung Cancer Drugs Market Share Analysis by Country, 2021 and 2030
  12. Europe Non Small Cell Lung Cancer Drugs Market Share Analysis by Type, 2021 and 2030
  13. Europe Non Small Cell Lung Cancer Drugs Market Share Analysis by Application, 2021 and 2030
  14. Europe Non Small Cell Lung Cancer Drugs Market Share Analysis by Country, 2021 and 2030
  15. Asia Pacific Non Small Cell Lung Cancer Drugs Market Share Analysis by Type, 2021 and 2030
  16. Asia Pacific Non Small Cell Lung Cancer Drugs Market Share Analysis by Application, 2021 and 2030
  17. Asia Pacific Non Small Cell Lung Cancer Drugs Market Share Analysis by Country, 2021 and 2030
  18. MEA Non Small Cell Lung Cancer Drugs Market Share Analysis by Type, 2021 and 2030
  19. MEA Non Small Cell Lung Cancer Drugs Market Share Analysis by Application, 2021 and 2030
  20. MEA Non Small Cell Lung Cancer Drugs Market Share Analysis by Country, 2021 and 2030
market statsville report image

Want to Review Complete Market Research Report

Request Sample
$3150  $2450 save 23%
$4950  $3850 save 25%
$7680  $5100 save 30%
Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Budget constrains? Get in touch with us for special pricing
Request Discount

Phone: +1 (888) 615 4898

Email: sales@regionalresearchreports.com

Chat with Us: Click here to start